A1 Group upgraded international capacity from Aflenz to Frankfurt and Milan to 400 Gbit/s, enhancing streaming, broadcasting, and gaming services with low latencies.…
DHL Group released a new press release about DHL Express launching a Label-Free Service for package returns globally, replacing traditional printing with a…
Mon Oct 14 08:47:12 – 2024 UTC — 阿斯利康的Enhertu已在中国获得有条件批准，用于治疗HER2突变转移性非小细胞肺癌。 Enhertu是由第一三共公司发现的一种特异性HER2定向DXd抗体药物共轭物（ADC），由阿斯利康和第一三共公司联合开发和商业化。 Destiny-Breast12研究设计 Destiny-Breast12是一项开放标签、多中心、国际性IIIb/IV期研究，旨在评估T-DXd对Her2+乳腺癌患者（伴有或不伴有脑转移）的疗效和安全性。 患者在接受抗HER2治疗方案后病情反复进展，并在晚期最多接受过2次全身治疗。
AstraZeneca's Enhertu has been conditionally approved in China as a therapy for HER2-mutant metastatic non-small cell lung cancer.
Ackermans & van Haaren (AvH) has committed €5 million to a €15 million private placement organized by agricultural technology company Biotalys NV (Euronext…
Randstad appoints Jesus Echevarria as COO; Chris Heutink departs after 30 years.
UCB has received FDA approval for new single-injection device options of BIMZELX® (bimekizumab-bkzx) in 320 mg doses, expanding administration choices for patients with…
Givaudan Taste & Wellbeing breaks ground on a new production facility in Indonesia, investing in expanding manufacturing in Southeast Asia for various food…
A1 Group announces SkyShowtime launch in Bulgaria, Serbia, Croatia, Slovenia, and North Macedonia, starting with A1 Bulgaria.
JPMorgan Chase released its third-quarter 2024 financial results. The firm has $4.2 trillion in assets and $346 billion in stockholders' equity. JPMorgan Chase…